ResMed Inc. (ASX:RMD)
Australia · Delayed Price · Currency is AUD 38.08
+0.17 (0.45%)
At close: Dec 15, 2025
ResMed Market Cap
ResMed has a market cap or net worth of 55.37 billion as of December 15, 2025. Its market cap has decreased by -2.54% in one year.
Market Cap
55.37B
Enterprise Value
54.56B
Revenue
7.95B
Ranking
n/a
PE Ratio
25.47
Stock Price
38.08
Market Cap Chart
Since June 2, 1995, ResMed's market cap has increased from 53.86M to 55.37B, an increase of 102,699.84%. That is a compound annual growth rate of 25.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 55.37B | 2.04% |
| Dec 31, 2024 | 54.27B | 46.20% |
| Dec 29, 2023 | 37.12B | -17.49% |
| Dec 30, 2022 | 44.98B | -14.11% |
| Dec 31, 2021 | 52.37B | 31.17% |
| Dec 31, 2020 | 39.93B | 25.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 88.73B |
| Pro Medicus | 24.49B |
| Cochlear | 17.23B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.16B |
| Ansell | 5.12B |
| Telix Pharmaceuticals | 4.65B |
| Mesoblast | 3.55B |